EMJ Interventional Cardiology最新文献

筛选

英文中文

Reinfection Rates Following Cardiovascular Implantable Electronic Device Reimplementation Post-device Primary Infection 心血管植入式电子设备初次感染后重新植入的再感染率

EMJ Interventional Cardiology Pub Date : 2024-03-27 DOI: 10.33590/emjintcardiol/11000027

O. Anyagwa, Fatema Rampurawala, Lama Alchaar, Taymaa Gharib, Miyukta Ravuri, Kulsum Fatima, Namrata Mishra, Rutvi Bhatt, Maha Essakkiraj, Rajeeka Tak, Maha Kassem

{"title":"Reinfection Rates Following Cardiovascular Implantable Electronic Device Reimplementation Post-device Primary Infection","authors":"O. Anyagwa, Fatema Rampurawala, Lama Alchaar, Taymaa Gharib, Miyukta Ravuri, Kulsum Fatima, Namrata Mishra, Rutvi Bhatt, Maha Essakkiraj, Rajeeka Tak, Maha Kassem","doi":"10.33590/emjintcardiol/11000027","DOIUrl":"https://doi.org/10.33590/emjintcardiol/11000027","url":null,"abstract":"Cardiovascular implantable electronic device (CIED) infections have become an increasing problem around the world, affecting one in 20 patients within 3 years of device implementation. Prevention of reinfection following CIED reimplantation is a prominent challenge. One of the most difficult aspects of managing CIED infections is the complexities of their diagnosis: with the complexities of many infections, timely and correct diagnosis becomes complicated, frequently causing delays in commencing proper therapy, and worsening disease severity. As patients receiving CIED therapy are now older, and possess significant comorbidities, they are at a higher risk of infection. The American Heart Association (AHA) has issued a statement to educate clinicians about CIED infections, and the required care for those with suspected or diagnosed infections. To prevent an infection from spreading, it is important to isolate the causative pathogen and perform testing for susceptibility, which is required for crucial choices, including routes and duration of antimicrobial therapy. This review aims to serve as a valuable resource for healthcare professionals, by synthesising current knowledge and best practices; and providing insights into preventive measures, diagnostic challenges, therapeutic strategies, and evidence-based approaches to diagnose and improve the management of CIED infections in an ageing and medically complex patient population.","PeriodicalId":505264,"journal":{"name":"EMJ Interventional Cardiology","volume":"54 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140376390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Should Coronary Artery Fistula Be Treated? A Review Throughout a Case Series 冠状动脉瘘应该治疗吗？病例系列回顾

EMJ Interventional Cardiology Pub Date : 2024-02-28 DOI: 10.33590/emjintcardiol/11000007

Mario Buitrago-Gomez, Carlos H. Salazar, Natalia Sarmiento, Yefferson Salinas, Natalia Moscoso, Juan Quiros, Melquisedec Galvis, Javier Beltran

{"title":"Should Coronary Artery Fistula Be Treated? A Review Throughout a Case Series","authors":"Mario Buitrago-Gomez, Carlos H. Salazar, Natalia Sarmiento, Yefferson Salinas, Natalia Moscoso, Juan Quiros, Melquisedec Galvis, Javier Beltran","doi":"10.33590/emjintcardiol/11000007","DOIUrl":"https://doi.org/10.33590/emjintcardiol/11000007","url":null,"abstract":"Background: Coronary artery disease (CAD) includes a wide spectrum of entities beyond the atherosclerotic disease. Coronary artery fistulas (CAF) represent an uncommon vascular abnormality that may cause several cardiovascular complications and symptoms, due to the coronary steal phenomena. Surgical or percutaneous closure should always be considered. The authors present a case series of patients with CAFs who developed cardiovascular manifestations, and underwent percutaneous closure safely and feasibly, with good clinical results.\u0000\u0000Case Summary: Five patients with CAFs were treated from 2021–2023; three were male (60%), the mean age was 59 years, the most common symptom was chest pain, and two patients presented in the context of unstable angina. The authors documented pulmonary hypertension in three patients, none of them with haemodynamic compromise of right ventricle. Two of the patients had documented ischaemia or haemodynamic significance due to the CAF. Finally, in two cases, no CAD was noted in coronary angiography. Percutaneous closure was done using a 6 Fr or 7 Fr sheath; guiding catheter 6 or 7 Fr through a workhorse guidewire, a microcatheter was placed in the coronary origin of the fistula, closure was done using a liquid embolisation system or delivering coils into the defect. The number and length of coils may vary depending on the fistula’s size.\u0000\u0000Discussion: The authors present five successful cases of percutaneous closure of symptomatic CAF, who presented with angina or dyspnoea as main symptoms. Once the diagnosis was made and further studies performed, the closure was decided based on the pulmonary hypertension or coronary steal phenomena.","PeriodicalId":505264,"journal":{"name":"EMJ Interventional Cardiology","volume":"12 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140420502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0